Coverage of new genetic technologies: what matters to insurers?
D001943:Breast Neoplasms; D003362:Cost-Benefit Analysis; D003550:Cystic Fibrosis; D003625:Data Collection; D020022:Genetic Predisposition to Disease; D005820:Genetic Testing; D015316:Genetic Therapy; D006579:Heterozygote; D006801:Humans; D007221:Industry; D007348:Insurance, Health; D007349:Insurance, Health, Reimbursement; D008403:Mass Screening; D016134:Organizational Policy; D011247:Pregnancy; D037841:Pregnant People; D014481:United States
Empirical Approach; Genetics and Reproduction